Annual D&A
$48.50M$7.27M+17.64%
Summary
- Current Value
- As of today, NVAX annual D&A is $48.50M, up +17.64% on
- Historical Performance
- NVAX annual D&A is up +283.03% over the past 3 years, and up +754.40% over the past 5 years
- All-Time High Comparison
- NVAX annual D&A is currently at its all-time high
- 3-Year Low Comparison
- NVAX annual D&A is +66.92% above its 3-year low of $29.05M reached on an earlier date
- Sector Comparison
- NVAX annual D&A is higher than 84.48% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $48.50M | +17.6% | +283.0% | +754.4% | +3961.6% | |
| Quarterly D&A | $6.59M | -48.1% | -21.1% | +455.2% | +1739.4% | |
| TTM D&A | $35.01M | -25.2% | +37.3% | +770.1% | +2622.0% | |
| Price | $8.67 | +0.7% | -29.4% | -93.1% | -82.6% | |
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual Total Expenses | $869.66M | -43.1% | -69.9% | +474.6% | +2147.2% | |
| Annual Operating Expenses | $716.19M | -36.0% | -74.6% | +452.6% | +1815.8% | |
| Annual Revenue | $682.16M | -30.6% | -40.5% | +3555.3% | +10000.0% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $48.50M | at high | |
| 5Y | $48.50M | at high | |
| All | $48.50M | at high |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $29.05M | N/A | +66.9% |
| 5Y | $4.89M | N/A | +892.8% |
| All | $253.60K | >+9999.0% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of NVAX?
As of today, NVAX annual D&A is $48.50M
What is 1-year change in NVAX annual D&A?
NVAX annual D&A is up +17.64% year-over-year
What is 3-year change in NVAX annual D&A?
NVAX annual D&A is up +283.03% over the past 3 years
How far is NVAX annual D&A from its all-time high?
NVAX annual D&A is currently at its all-time high
How does NVAX annual D&A rank versus sector peers?
NVAX annual D&A is higher than 84.48% of companies in Healthcare sector
When is NVAX next annual earnings release?
The next annual earnings release for NVAX is on
Quarterly D&A
$6.59M$978.00K-12.93%
Summary
- Current Value
- As of today, NVAX quarterly D&A is $6.59M, down -12.93% on
- Historical Performance
- NVAX quarterly D&A is down -48.15% year-over-year, and down -21.11% over the past 3 years
- All-Time High Comparison
- NVAX quarterly D&A is currently -48.15% below its historical high of $12.70M set on
- 3-Year Low Comparison
- NVAX quarterly D&A is at its 3-year low
- Sector Comparison
- NVAX quarterly D&A is higher than 79.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $6.59M | -12.9% | -48.1% | -21.1% | +455.2% | |
| Annual D&A | $48.50M | – | +17.6% | +283.0% | +754.4% | |
| TTM D&A | $35.01M | -14.9% | -25.2% | +37.3% | +770.1% | |
| Price | $8.67 | +0.6% | +0.7% | -29.4% | -93.1% | |
| Quarterly SG&A | $31.66M | -27.4% | -55.3% | -74.2% | -44.4% | |
| Quarterly Total Expenses | $272.82M | +105.5% | +32.6% | -69.8% | -23.0% | |
| Quarterly Operating Expenses | $130.05M | +9.0% | -16.4% | -69.0% | -32.7% | |
| Quarterly Revenue | $70.45M | -70.5% | -16.6% | -90.4% | -55.1% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $12.52M | N/A | -47.4% |
| 3Y | $12.70M | -48.1% | |
| 5Y | $12.70M | -48.1% | |
| All | $12.70M | -48.1% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.59M | at low | |
| 3Y | $6.59M | at low | |
| 5Y | $1.79M | N/A | +267.1% |
| All | -$1.36M | +583.8% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of NVAX?
As of today, NVAX quarterly D&A is $6.59M
What is NVAX quarterly D&A most recent change?
NVAX quarterly D&A was down -12.93% on September 30, 2025
What is 1-year change in NVAX quarterly D&A?
NVAX quarterly D&A is down -48.15% year-over-year
How far is NVAX quarterly D&A from its all-time high?
NVAX quarterly D&A is currently -48.15% below its historical high of $12.70M set on September 30, 2024
How does NVAX quarterly D&A rank versus sector peers?
NVAX quarterly D&A is higher than 79.07% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on
TTM D&A
$35.01M$6.12M-14.87%
Summary
- Current Value
- As of today, NVAX TTM D&A is $35.01M, down -14.87% on
- Historical Performance
- NVAX TTM D&A is down -25.16% year-over-year, and up +37.25% over the past 3 years
- All-Time High Comparison
- NVAX TTM D&A is currently -27.82% below its historical high of $48.50M set on
- 3-Year Low Comparison
- NVAX TTM D&A is +20.48% above its 3-year low of $29.05M reached on an earlier date
- Sector Comparison
- NVAX TTM D&A is higher than 81.11% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $35.01M | -14.9% | -25.2% | +37.3% | +770.1% | |
| Annual D&A | $48.50M | – | +17.6% | +283.0% | +754.4% | |
| Quarterly D&A | $6.59M | -12.9% | -48.1% | -21.1% | +455.2% | |
| Price | $8.67 | +0.6% | +0.7% | -29.4% | -93.1% | |
| TTM SG&A | -$18.47B | -7769.4% | -4559.8% | -4590.6% | -10000.0% | |
| TTM Revenue | $1.06B | -1.3% | +20.3% | -42.4% | +420.0% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $48.50M | N/A | -27.8% |
| 3Y | $48.50M | -27.8% | |
| 5Y | $48.50M | -27.8% | |
| All | $48.50M | -27.8% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $35.01M | at low | |
| 3Y | $29.05M | N/A | +20.5% |
| 5Y | $4.89M | N/A | +616.6% |
| All | -$780.00K | +4587.8% |
TTM D&A History
FAQ
What is the current TTM D&A of NVAX?
As of today, NVAX TTM D&A is $35.01M
What is NVAX TTM D&A most recent change?
NVAX TTM D&A was down -14.87% on September 30, 2025
What is 1-year change in NVAX TTM D&A?
NVAX TTM D&A is down -25.16% year-over-year
How far is NVAX TTM D&A from its all-time high?
NVAX TTM D&A is currently -27.82% below its historical high of $48.50M set on December 31, 2024
How does NVAX TTM D&A rank versus sector peers?
NVAX TTM D&A is higher than 81.11% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on
Data Sources & References
- NVAX Official Website www.novavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1000694/000100069425000046/0001000694-25-000046-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000694/000100069425000004/0001000694-25-000004-index.htm
- NVAX Profile on Yahoo Finance finance.yahoo.com/quote/NVAX
- NVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvax